83 FR 27634 - Importer of Controlled Substances Application: Restek Corporation
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 114 (June 13, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 114 (June 13, 2018)
| Page Range | 27634-27634 | |
| FR Document | 2018-12680 |
[Federal Register Volume 83, Number 114 (Wednesday, June 13, 2018)] [Notices] [Page 27634] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-12680] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Restek Corporation ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 13, 2018. Such persons may also file a written request for a hearing on the application on or before July 13, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on February 20, 2018, Restek Corporation, 110 Benner Cr., Bellefonte, PA 16823 applied to be registered as an importer of the Schedule I controlled substance Tetrahydrocannibinols (7370). The company plans to import the controlled substance in bulk for the manufacture of analytical reference material which, in its final form, is an exempted product. Dated: June 6, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-12680 Filed 6-12-18; 8:45 am] BILLING CODE 4410-09-P
![27634 Federal Register / Vol. 83, No. 114 / Wednesday, June 13, 2018 / Notices
The company plans to import the connection with suspension, denial, or Faculty grant program, submitted to the
listed controlled substances in dosage revocation of registration) has been Division of Research Programs.
form to conduct clinical trials. redelegated to the Assistant 2. Date: July 24, 2018. This meeting
Approval of permit applications will Administrator of the DEA Diversion will discuss applications on the topics
occur only when the registrant’s activity Control Division (‘‘Assistant of Literature, History, and the Arts, for
is consistent with what is authorized Administrator’’) pursuant to section 7 of the NEH-Mellon Fellowships, submitted
under to 21 U.S.C.952 (a)(2). 28 CFR part 0, appendix to subpart R. to the Division of Research Programs.
Authorization will not extend to the In accordance with 21 CFR 3. Date: July 25, 2018. This meeting
import of FDA approved or non- 1301.34(a), this is notice that on will discuss applications on the topics
approved finished dosage forms for February 20, 2018, Restek Corporation, of Literature, Philosophy, and Religion,
commercial sale. 110 Benner Cr., Bellefonte, PA 16823 for the Awards for Faculty grant
Dated: June 6, 2018. applied to be registered as an importer program, submitted to the Division of
John J. Martin, of the Schedule I controlled substance Research Programs.
Assistant Administrator. Tetrahydrocannibinols (7370). 4. Date: July 26, 2018. This meeting
The company plans to import the will discuss applications on the topics
[FR Doc. 2018–12682 Filed 6–12–18; 8:45 am]
controlled substance in bulk for the of History and Politics, for the Awards
BILLING CODE 4410–09–P
manufacture of analytical reference for Faculty grant program, submitted to
material which, in its final form, is an the Division of Research Programs.
exempted product. 5. Date: July 26, 2018. This meeting
DEPARTMENT OF JUSTICE
Dated: June 6, 2018.
will discuss applications for
Drug Enforcement Administration Fellowships for Advanced Social
John J. Martin,
Science Research on Japan, submitted to
[Docket No. DEA–392] Assistant Administrator. the Division of Research Programs.
[FR Doc. 2018–12680 Filed 6–12–18; 8:45 am] 6. Date: July 27, 2018. This meeting
Importer of Controlled Substances BILLING CODE 4410–09–P will discuss applications on the topics
Application: Restek Corporation
of American History and Studies, and
ACTION: Notice of application. Social Sciences, for the Awards for
NATIONAL FOUNDATION ON THE Faculty grant program, submitted to the
DATES: Registered bulk manufacturers of ARTS AND THE HUMANITIES Division of Research Programs.
the affected basic classes, and Because these meetings will include
applicants therefore, may file written Meeting of Humanities Panel review of personal and/or proprietary
comments on or objections to the financial and commercial information
AGENCY: National Endowment for the given in confidence to the agency by
issuance of the proposed registration on
Humanities. grant applicants, the meetings will be
or before July 13, 2018. Such persons
may also file a written request for a ACTION: Notice of meeting. closed to the public pursuant to sections
hearing on the application on or before 552b(c)(4) and 552b(c)(6) of Title 5,
SUMMARY: The National Endowment for U.S.C., as amended. I have made this
July 13, 2018. the Humanities will hold six meetings
ADDRESSES: Written comments should determination pursuant to the authority
of the Humanities Panel, a federal granted me by the Chairman’s
be sent to: Drug Enforcement advisory committee, during July 2018.
Administration, Attention: DEA Federal Delegation of Authority to Close
The purpose of the meetings is for panel Advisory Committee Meetings dated
Register Representative/DRW, 8701 review, discussion, evaluation, and
Morrissette Drive, Springfield, Virginia April 15, 2016.
recommendation of applications for
22152. All requests for hearing must be financial assistance under the National Dated: June 7, 2018.
sent to: Drug Enforcement Foundation on the Arts and Humanities Elizabeth Voyatzis,
Administration, Attn: Administrator, Act of 1965. Committee Management Officer.
8701 Morrissette Drive, Springfield, [FR Doc. 2018–12653 Filed 6–12–18; 8:45 am]
DATES: See SUPPLEMENTARY INFORMATION
Virginia 22152. All request for hearing
for meeting dates. The meetings will BILLING CODE 7536–01–P
should also be sent to: (1) Drug
open at 8:30 a.m. and will adjourn by
Enforcement Administration, Attn:
5:00 p.m. on the dates specified below.
Hearing Clerk/LJ, 8701 Morrissette
ADDRESSES: The meetings will be held at NUCLEAR REGULATORY
Drive, Springfield, Virginia 22152; and
Constitution Center at 400 7th Street COMMISSION
(2) Drug Enforcement Administration,
Attn: DEA Federal Register SW, Washington, DC 20506, unless [Docket Nos. 50–289 and 50–320; NRC–
Representative/DRW, 8701 Morrissette otherwise indicated. 2018–0115]
Drive, Springfield, Virginia 22152. FOR FURTHER INFORMATION CONTACT:
Elizabeth Voyatzis, Committee Exelon Generation Company, LLC;
SUPPLEMENTARY INFORMATION: The
Management Officer, 400 7th Street SW, Three Mile Island Nuclear Station,
Attorney General has delegated his
Room 4060, Washington, DC 20506; Units 1 and 2; Suspension of Security
authority under the Controlled
(202) 606–8322; evoyatzis@neh.gov. Measures in an Emergency or During
Substances Act to the Administrator of
Severe Weather
the Drug Enforcement Administration SUPPLEMENTARY INFORMATION: Pursuant
(DEA), 28 CFR 0.100(b). Authority to to section 10(a)(2) of the Federal AGENCY: Nuclear Regulatory
amozie on DSK3GDR082PROD with NOTICES1
exercise all necessary functions with Advisory Committee Act (5 U.S.C. Commission.
respect to the promulgation and App.), notice is hereby given of the ACTION: Exemption; issuance.
implementation of 21 CFR part 1301, following meeting:
incident to the registration of 1. Date: July 24, 2018. This meeting SUMMARY: The U.S. Nuclear Regulatory
manufacturers, distributors, dispensers, will discuss applications on the topics Commission (NRC) is issuing an
importers, and exporters of controlled of American Literature and Studies, the exemption from regulatory requirements
substances (other than final orders in Arts, and Media, for the Awards for in response to an August 1, 2017,
VerDate Sep<11>2014 18:01 Jun 12, 2018 Jkt 244001 PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 E:\FR\FM\13JNN1.SGM 13JNN1](https://thefederalregister.org/doc/83_FR_27748/page/1.svg)
Document Created: 2018-06-12 23:59:09
Document Modified: 2018-06-12 23:59:09
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 13, 2018. Such persons may also file a written request for a hearing on the application on or before July 13, 2018. | |
| FR Citation | 83 FR 27634 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR